Evidence map›Paper›PMID 42851676›Full record

ArticleFrontiers in microbiology2026

Comprehensive genomic characterization of multidrug-resistant

Nargis Kaur Bali, Aktarul Islam Siddique, Umaya Majid, Dona Mathew, Susheem Ramakrishnan, Biswajyoti Borkakoty

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nargis Kaur BaliSher-i-Kashmir Institute of Medical Sciences, Srinagar, India.
Aktarul Islam SiddiqueRegional Medical Research Centre (ICMR), Dibrugarh, India.
Umaya MajidSher-i-Kashmir Institute of Medical Sciences, Srinagar, India.
Dona MathewSher-i-Kashmir Institute of Medical Sciences, Srinagar, India.
Susheem RamakrishnanSher-i-Kashmir Institute of Medical Sciences, Srinagar, India.
Biswajyoti BorkakotyRegional Medical Research Centre (ICMR), Dibrugarh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: Ninety-six non-duplicate clinical Results: Phenotypic analysis showed carbapenem resistance in 93/96 (96.9%) isolates. Genomic analysis identified 32 sequence types, with ST515 (37.5%; 27/72) as the predominant lineage, while KL62 (60.0%; 54/90) was the most common capsular locus. The predominant carbapenemase gene was Conclusion: This study provides a comprehensive genomic characterization of MDR

Indexed as

blaOXA-232carbapenem resistanceKlebsiella pneumoniaeMLSTphylogenomicsresistomewhole-genome sequencing

Identifiers

PMID42851676
PMCPMC13646146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.